Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2021 | 07-2021 | 04-2021 | 01-2021 | 10-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 148 | 131 | 2,728 | 1,159 | N/A |
| Accounts receivable | -102 | -64 | -48 | -41 | -73 |
| Other Working Capital | -204 | -160 | -890 | -51 | 801 |
| Other Operating Activity | -2,319 | -2,409 | -6,069 | -4,642 | -2,003 |
| Operating Cash Flow | $-2,477 | $-2,503 | $-4,279 | $-3,576 | $-1,274 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -85 | N/A | N/A | N/A |
| Net Acquisitions | -200 | -1,000 | -81 | 0 | N/A |
| Other Investing Activity | -756 | 0 | -45 | -6 | -165 |
| Investing Cash Flow | $-956 | $-1,085 | $-127 | $-6 | $-165 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -33 | -33 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 0 | 11,500 | 256 |
| Other Financing Activity | 25 | 0 | 465 | 3,543 | 200 |
| Financing Cash Flow | $-7 | $-33 | $465 | $15,043 | $456 |
| Beginning Cash Position | 5,781 | 9,402 | 13,342 | 1,880 | 2,863 |
| End Cash Position | 2,340 | 5,781 | 9,402 | 13,342 | 1,880 |
| Net Cash Flow | $-3,441 | $-3,621 | $-3,940 | $11,462 | $-983 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,477 | -2,503 | -4,279 | -3,576 | -1,274 |
| Capital Expenditure | -1 | -85 | N/A | N/A | N/A |
| Free Cash Flow | -2,478 | -2,588 | -4,279 | -3,576 | -1,274 |